Published in Blood Weekly, January 23rd, 2003
W.K. Hofmann and colleagues compared "gene patterns of expression in purified CD34+ bone marrow cells from seven patients with low-risk myelodysplastic syndrome (MDS) and four patients with high-risk MDS ... with expression data from CD34+ bone marrow cells from four healthy control subjects."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.